Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Robin, Alan L., M.D.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients aged 18 years or older
Patients currently using topical ocular antihypertensive medications at the time of enrollment in at least one eye, and who have been using these drops consistently for a period of at least three months prior to enrollment.
Patients with primary open angle glaucoma, pigmentary glaucoma, exfoliation glaucoma, ocular hypertension, normal-tension glaucoma, neovascular glaucoma, uveitic glaucoma and chronic narrow angle glaucoma.
Patients CAN be enrolled even if they have co-existing morbidities such as Parkinson's Disease or arthritis
You may not be if
Patients who do not instill their own eye drops
Patients who are not expected to still be using topical antihypertensive medications at the time of study follow-up
Patients with no light perception vision
Patients with a history of adverse reaction to artificial tears or any component of artificial tears
Patients who have a typical follow-up period of greater than 6 months
Patients who have not completed a Humphrey Visual Field C24-2 or C10-2 within 7 months of enrollment or study exit.
Clareo Health | An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation
